Gao E, director and deputy general manager of Xingqi, was elected as a member of CPPCC Shenyang in January 2022.

China's new national medical insurance catalog came into effect on 

January 1st, 2022. Xingqi Zirun® Cyclosporine Eye Drops (II) passed the national medical insurance negotiations and entered the catalog, which would allow more dry eye patients to benefit from this safer and more effective, comfortable and affordable dry eye treatment option.

Xingqi was named to the “Best Employer 2021 in China – the Best Employer in Shenyang” on January 12, 2022. 

In another round of implementation of the Xingqi “Aiding the Disabled Charity Program” on January 13, 2022, the company donated RMB 700,000 to the Shenyang Foundation for Disabled Persons.

Xingqi was named to the Excellent Case Award 2021 by 100doc.com.cn on January 18, 2022, on the occasion of which Xingqi's digital interaction business became a new platform for academic exchanges.

Xingqi was named to the “vice-chairman unit” by the Shenyang Federation of Industry and Commerce in February 2022. 

Xingqi received approval for the establishment of the Post-doctoral Innovation Practice Base of Liaoning Province on February 9, 2022.

The on-site review of Xingqi's application for the Governor Quality Award was completed successfully on February 24, 2022.

Party committee secretary, chairman and general manager Newsun was named to “the Most Beautiful Volunteer 2021 of Shenyang” by Shenyang Civilization Office on March 16, 2022.  

Gao E, director and deputy general manager of Xingqi, was named to “the Most Beautiful Role Model (Employee) Volunteer” for the 2021 Shenyang Learning from Lei Feng Volunteer Service by the Shenyang Federation of Trade Unions on March 16, 2022.

Xingqi was named to the” 2021 National ADR Monitoring and Evaluation Unit” for outstanding performance in fulfilling the responsibilities of a pharmaceutical, medical device and cosmetics company by the Center for Drug Reevaluation, NMPA and National Center for ADR Monitoring on March 24, 2022.

Xingqi doated RMB 100,000 to the National Defense Education Foundation of Liaoning Province in support of epidemic prevention and control and other charity programs in Shenyang on March 25, 2022. 

Xingqi was presented the “2021 Health Promotion Social Responsibility Award” by the Guangzhou Daily Group on April 1, 2022. 

Xingqi was presented the plaque for “Joint Innovation Center” by the Industrial Technology Research Institute of Liaoning Province (the Important Technology Innovation and R&D Base Construction Engineering Center of Liaoning Province) on April 26, 2022. 

Xingqi donated RMB 1 million to Linquan County, Anhui Province in support of the local poverty alleviation on May 18, 2022.  

Xingqi was named to the “Listed Pharmaceutical Company with the Greatest Growth Value” and also the vice-president unit of China Medical Pharmaceutical Material Association at the Yangtze River Wealth Forum on July 16, 2022.

Xingqi received the “Silver Medal of Liaoning Provincial Governor Quality Award” by the Liaoning Provincial People's Government on July 28, 2022.

Liu Jidong, chairman of Xingqi, was named as “Model Worker of Liaoning Province” on August 24, 2022. 

On August 27, 2022, Xingqi was named to “Outstanding Contribution to the Industry” by the Ophthalmology Committee of CAME (OCC). Chairman Liu Jidong was named to “Management Excellence”. The Ailic-Tech proprietary technique of Xingqi Zirun® Cyclosporine Eye Drops (II) was named to “Progress of Ophthalmology Science and Technology”. 

On September 7, 2022, Xingqi was selected to the “Best Brand List” of China Medical Pharmaceutical Material Association. Chairman Liu Jidong was named to “Leader in Pharmaceutical Industry”. Xingqi Aierming® (red) Naphazoline Hydrochloride, Chlorphenamine Maleate and Vitamin B12 Eye Drops was listed among “the Most Popular Products in Retail Pharmacies”. 

On September 22, 2022, Xingqi won the award of “Top 50 Value of Listed Companies in GEM” at the 16th Awards of the Value of Listed Companies in China hosted by Securities Daily.

Xingqi was selected as National Intellectual Property Model Enterprise by the China National Intellectual Property Administration on September 23, 2022.

Xingqi was approved by the Office of the National Postdoctoral Management Committee to set up a national-level postdoctoral research station on October 12, 2022. 

In November, 2022, Xingqi Pharmaceutical Packaging Research Office was selected as “Excellent Service Organization” of Shenyang Scientific and Technological Innovation Platform by the Important Technology Innovation and Scientific and Technological Achievements Transformation Center of Shenyang Municipal Science and Technology Bureau.